Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372944
Status:
COMPLETED
Last Update Posted:
2014-08-13
First Post:
2006-09-05
Brief Title:
AZD6244 vs Capecitabine Xeloda in Patients With Advanced or Metastatic Pancreatic Cancer Who Have Failed First Line Gemcitabine Therapy
Sponsor:
AstraZeneca
Organization:
AstraZeneca